Bayer AG ADR

BAYRY: OTCM (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.v>LOCK|x@LOCK|VPF

Bayer's Near-Term Outlook Dominated by Crop Science Uncertainty and Generic Pressures

Business Strategy and Outlook

We believe Bayer has created a narrow economic moat on the basis of the competitive advantages of the healthcare group. Bayer is evaluating the divestitures of the crop science and consumer healthcare businesses, which appear to hold few synergies with the prescription drug business.

Sponsor Center